Sign in

CIK 0001935979 · Large accelerated filer

Biohaven Ltd.

Sign in to watch
Ticker
BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Virgin Islands, British
Entity type
operating
Phone
203-404-0410
Business address
215 CHURCH STREET, NEW HAVEN, CT, 06510
Former names
Biohaven Research Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-10-03 CHILDS JOHN W Director Option exercise · Stock Options (Right to Buy) −4,119 0
2022-10-03 CHILDS JOHN W Director Option exercise · Stock Options (Right to Buy) −5,998 0
2022-10-03 CHILDS JOHN W Director Grant or award · Stock Options (Right to Buy) +125,000 125,000
2022-10-03 HUGIN ROBERT J Director Other acquisition +1,450 1,450
2022-10-03 HUGIN ROBERT J Director Other acquisition +1,708 3,158
2022-10-03 HUGIN ROBERT J Director Option exercise +4,119 $4.84 $20K 7,277
2022-10-03 HUGIN ROBERT J Director Option exercise +5,998 $3.56 $21K 13,275
2022-10-03 HUGIN ROBERT J Director Option exercise +9,474 $3.39 $32K 22,749
2022-10-03 HUGIN ROBERT J Director Shares withheld for taxes −3,263 $7.50 $24K 19,486
2022-10-03 HUGIN ROBERT J Director Other acquisition · Stock Options (Right to Buy) +4,119 4,119
2022-10-03 HUGIN ROBERT J Director Other acquisition · Stock Options (Right to Buy) +5,998 5,998
2022-10-03 HUGIN ROBERT J Director Other acquisition · Stock Options (Right to Buy) +9,474 9,474
2022-10-03 HUGIN ROBERT J Director Option exercise · Stock Options (Right to Buy) −4,119 0
2022-10-03 HUGIN ROBERT J Director Option exercise · Stock Options (Right to Buy) −5,998 0
2022-10-03 HUGIN ROBERT J Director Option exercise · Stock Options (Right to Buy) −9,474 0
2022-10-03 HUGIN ROBERT J Director Grant or award · Stock Options (Right to Buy) +125,000 125,000
2022-10-03 Buten Matthew Chief Financial Officer Other acquisition +3,088 3,088
2022-10-03 Buten Matthew Chief Financial Officer Other acquisition +18,750 21,838
2022-10-03 Buten Matthew Chief Financial Officer Option exercise +1,550 $6.37 $10K 23,388
2022-10-03 Buten Matthew Chief Financial Officer Option exercise +11,450 $6.37 $73K 34,838

Page 14 of 18 · 355 trades